Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
NCT ID: NCT01574053
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
35000 participants
OBSERVATIONAL
2012-07-31
2062-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)
NCT01590589
Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)
NCT01554033
REGISTRY-JHD - an Observational Study of the European Huntington's Disease Network (EHDN)
NCT01590602
Assessment of the Psychological, Cognitive and Social Resources of Applicants for Huntington's Disease and Presymptomatic Genetic Testing
NCT02134561
Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study
NCT02563418
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Controls: This group comprises the comparator study population and consists of individuals who do not carry the HD expansion mutation.
These two major categories can be further subdivided into six different subgroups of eligible individuals:
* Manifest/Motor-manifest HD: Carriers with clinical features that are regarded in the opinion of the investigator as diagnostic of HD.
* Pre-Manifest/-Motor-manifest HD: Carriers without clinical features regarded as diagnostic of HD.
* Genotype Unknown: This group includes a first or second degree relative (i.e., related by blood to a carrier) who has not undergone predictive testing for HD and therefore has an undetermined carrier status.
* Genotype Negative: This group includes a first or second degree relative (i.e., related by blood to a carrier) who has undergone predictive testing for HD and is known not to carry the HD expansion mutation.
* Family Control: Family members or individuals not related by blood to carriers (e.g., spouses, partners, caregivers).
* Community Controls: Individuals unrelated to HD carriers who did not grow up in a family affected by HD. Data collected from community controls will be used for generation of normative data for sub-studies.
Participant status will be captured in the study database using 2 variables: 1) Investigator Determined Status: this will be based on clinical signs and symptoms and genotyping performed as part of medical care, and will be updated at every visit; and 2) Research Genotyping Status: this will be based on genotyping conducted as part of Enroll-HD study procedures. Based on research genotyping, participants will be reclassified under this variable from Genotype Unknown to 'Carriers' or 'Controls'. Investigators and participants will be blinded to this reclassification.
* Individuals with choreic movement disorders in the context of a negative test for the HD gene mutation.
* For Community Controls: those individuals with a major central nervous system disorder will be excluded (e.g. stroke, Parkinson's disease, multiple sclerosis, etc.).
Participants under 18 may be eligible to participate (if they have juvenile-onset HD).
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CHDI Foundation, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bernhard G Landwehrmeyer, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Ulm
Jamie Levey
Role: STUDY_DIRECTOR
CHDI Foundation, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama
Birmingham, Alabama, United States
St. Joseph's Hospital and Medical Center
Phoenix, Arizona, United States
University of California - Irvine Medical Center
Irvine, California, United States
Loma Linda Medical Center
Loma Linda, California, United States
University of California - Los Angeles
Los Angeles, California, United States
University of California - Davis
Sacramento, California, United States
University of California - San Diego
San Diego, California, United States
University of California - San Francisco
San Francisco, California, United States
Cenexel Rocky Mountain Clinical Research, LLC
Englewood, Colorado, United States
University of Connecticut
Farmington, Connecticut, United States
Georgetown University
Washington D.C., District of Columbia, United States
University of Florida Board of Trustees
Gainesville, Florida, United States
University of Miami
Miami, Florida, United States
University of South Florida, HDSA Center of Excellence at USF
Tampa, Florida, United States
Emory University, Wesley Woods Health Center
Atlanta, Georgia, United States
Georgia Health Sciences University
Augusta, Georgia, United States
Northwestern University
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
University of Illinois College of Medicine at Rockford
Rockford, Illinois, United States
Indiana University
Indianapolis, Indiana, United States
University of Iowa
Iowa City, Iowa, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Hereditary Neurological Disease Center
Wichita, Kansas, United States
University of Louisville
Louisville, Kentucky, United States
University of Maryland School of Medicine
Baltimore, Maryland, United States
Johns Hopkins University
Baltimore, Maryland, United States
Boston University Medical Center
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
Wayne State University
Detroit, Michigan, United States
Hennepin County Medical Center
Minneapolis, Minnesota, United States
Washington University in St. Louis
St Louis, Missouri, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Cleveland Clinic - Las Vegas
Las Vegas, Nevada, United States
Cooper University Hospital
Camden, New Jersey, United States
Rutgers, the State University of New Jersey
New Brunswick, New Jersey, United States
Albany Medical College
Albany, New York, United States
Columbia University
New York, New York, United States
University of Rochester
Rochester, New York, United States
Duke University
Durham, North Carolina, United States
Wake Forest School of Medicine
Winston-Salem, North Carolina, United States
Sanford Health
Fargo, North Dakota, United States
University of Cincinatti
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
The Ohio State University
Columbus, Ohio, United States
Oregon Health and Science University
Portland, Oregon, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
University of South Carolina
Columbia, South Carolina, United States
University of Tennessee Health Science Center
Memphis, Tennessee, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Baylor College of Medicine
Houston, Texas, United States
University of Texas Health Science Center
Houston, Texas, United States
University of Utah
Salt Lake City, Utah, United States
University of Vermont
Burlington, Vermont, United States
University of Virginia
Charlottesville, Virginia, United States
Virginia Commonwealth University Parkinson's and Movement Disorders Center
Henrico, Virginia, United States
Virginia Commonwealth University
Richmond, Virginia, United States
Booth Gardner Parkinson's Care Center (Evergreen Health)
Kirkland, Washington, United States
University of Washington Medical Center
Seattle, Washington, United States
University of Wisconsin - Madison
Madison, Wisconsin, United States
Instituto de Neurociencias Buenos Aires (INEBA)
Buenos Aires, , Argentina
Westmead Hospital
Westmead, New South Wales, Australia
Monash University
Melbourne, Victoria, Australia
The Neurosciences Unit - North Metropolitan Hospital
Perth, Western Australia, Australia
University of Melbourne, Royal Melbourne Hospital
Parkville, , Australia
Universitatsklinik Innsbruck
Innsbruck, , Austria
University Hospitals Leuven
Leuven, Vlaams-Brabant, Belgium
Bruxelles - Erasme
Brussels, , Belgium
Institut de Pathologie et de Génétique (IPG)
Charleroi, , Belgium
Hôpital du Beau Vallon ASBL
Saint-Servais, , Belgium
University of Calgary, Movement Disorders Program
Calgary, Alberta, Canada
University of Alberta (Glenrose)
Edmonton, Alberta, Canada
University of Alberta Hospital in Edmonton
Edmonton, Alberta, Canada
University of British Columbia
Vancouver, British Columbia, Canada
Nova Scotia Health Authority
Halifax, Nova Scotia, Canada
Centre for Movement Disorders
Markham, Ontario, Canada
The Ottawa Hospital
Ottawa, Ontario, Canada
North York General Hospital
Toronto, Ontario, Canada
CHUM Hospital of Notre Dame
Montreal, Quebec, Canada
CETRAM
Santiago, , Chile
Universidad de Antioquia, Grupo de Neurociencias
MedellÃn, Antioquia, Colombia
Servicios Médicos MS, ClÃnica de Marly
Bogotá, Cundinamarca, Colombia
University Hospital of Aarhus
Aarhus, , Denmark
University Hospital of Copenhagen
Copenhagen, , Denmark
University Hospital of Odense
Odense, , Denmark
Hôpitaux Universitaires de Strasbourg Hôpital de Hautepierre-Service de Neurologie
Strasbourg, Alsace Lorraine, France
CHU Amiens-Picardie
Amiens, , France
CHU Angers, Centre de Référence Maladies Neurogénétiques
Angers, , France
Bordeaux - Huntington Disease competencies center
Bordeaux, , France
CHU Gabriel-Montpied
Clermont-Ferrand, , France
Hôpital Henri Mondor, Centre d'Investigation Clinique
Créteil, , France
Lille-Amiens - Huntington Disease Constituent site
Lille, , France
Hôpital La Timone
Marseille, , France
CHU Montpellier
Montpellier, , France
Institut du Cerveau et de la Moelle Epinière
Paris, , France
Hôpital Purpan, Centre d'Investigation Clinique
Toulouse, , France
University Hospital Aachen
Aachen, , Germany
University of Berlin
Berlin, , Germany
St. Josef und St. Elisabeth Hospital
Bochum, , Germany
University Hospital Carl Gustav Carus Dresden
Dresden, , Germany
University Hospital Erlangen
Erlangen, , Germany
University Medical Center Freiburg
Freiburg im Breisgau, , Germany
Paracelsus Elena Klinik Kassel
Kassel, , Germany
University Hospital Schleswig-Holstein
Lübeck, , Germany
University Hospital Giessen and Marburg
Marburg, , Germany
Technical University of Munich
Munich, , Germany
George-Huntington-Institut GmbH
Münster, , Germany
kbo-Isar-Amper-Klinikum Taufkirchen (Vils)
Taufkirchen, , Germany
University Hopsital of Ulm
Ulm, , Germany
University Hospital of Wuerzburg
Würzburg, , Germany
Beaumont Hospital
Dublin, Republic of Ireland, Ireland
Fondazione IRCCS Istituto Neurologico Carlo Besta - Genetics
Milan, MI, Italy
Bari Policlinico General Hospital
Bari, , Italy
IRCCS Istituto delle Scienze Neurologiche di Bologna
Bologna, , Italy
Università degli Studi di Genova (DINOGMI)
Genoa, , Italy
Fondazione IRCCS Istituto Neurologico Carlo Besta - Neurology
Milan, , Italy
University of Naples
Napoli, , Italy
Università Cattolica del Sacro Cuore
Rome, , Italy
Lega Italiana Ricerca Huntington (LIRH)
Rome, , Italy
Azienda Ospedaliera Sant'Andrea
Rome, , Italy
University Medical Center Groningen
Groningen, , Netherlands
Leiden University Medical Centre
Leiden, , Netherlands
Clinical Trial Center Maastricht B.V.
Maastricht, , Netherlands
Auckland City Hospital
Auckland, , New Zealand
New Zealand Brain Research Institute at University of Otago
Christchurch, , New Zealand
Wellington Hospital
Wellington, , New Zealand
Copernicus Podmiotem Leczniczym sp. z o.o.
Gdansk, , Poland
Krakowska Akademia Neurologii Sp. z o.o
Katowice, , Poland
Krakow - Krakowska Akademia Neurologii
Krakow, , Poland
Solumed Centrum Medyczne
Poznan, , Poland
Medical University of Warsaw
Warsaw, , Poland
Institute of Psychiatry and Neurology, Warsaw
Warsaw, , Poland
Hospital Prof Doutor Fernando Fonseca
Amadora, , Portugal
Hospital Universitário de Coimbra
Coimbra, , Portugal
Central Lisbon Hospital
Lisbon, , Portugal
Hospital de Santa Maria / Instituto de Medicina Molecular
Lisbon, , Portugal
Hospital Universitário de São João
Porto, , Portugal
Hospital Infanta Cristina, Badajoz
Badajoz, , Spain
Hospital de Cruces
Barakaldo, , Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, , Spain
Hospital Mare de Déu de la Mercè
Barcelona, , Spain
Fundacion Clinic per a La Recerca Biomèdica
Barcelona, , Spain
Hospital Universitari de Bellvitge
Barcelona, , Spain
Hospital Universitario de Burgos
Burgos, , Spain
Hospital Universitario Ramón y Cajal
Madrid, , Spain
Fundación Jiménez DÃaz
Madrid, , Spain
Hospital Son Espases
Palma de Mallorca, , Spain
Complejo Hospitalario de Navarra
Pamplona, , Spain
Fundacion Hospital Universitario La Fe
Valencia, , Spain
Siloah AG
Gümligen, , Switzerland
University Hospital Zurich
Zurich, , Switzerland
Royal Devon and Exeter NHS Foundation Trust
Exeter, Devon, United Kingdom
Leicestershire Partnership
Narborough, Leicestershire, United Kingdom
North Bristol NHS Trust
Bristol, UK, United Kingdom
Fife Health Board
Kirkcaldy, UK, United Kingdom
Betsi Cadwaladr University Health Board
Wrexham, UK, United Kingdom
University of Aberdeen
Aberdeen, , United Kingdom
Birmingham and Solihull Mental Health NHS Foundation Trust
Birmingham, , United Kingdom
University of Cambridge
Cambridge, , United Kingdom
Cardiff University
Cardiff, , United Kingdom
Tayside Health Board
Dundee, , United Kingdom
Lothian Health Board
Edinburgh, , United Kingdom
Greater Glasgow Health Board
Glasgow, , United Kingdom
Ayrshire Central Hospital
Kilmarnock, , United Kingdom
NHS Forth Valley
Larbert, , United Kingdom
Leeds Teaching Hospitals
Leeds, , United Kingdom
The Walton Centre
Liverpool, , United Kingdom
Guy's and St. Thomas's NHS Foundation Trust
London, , United Kingdom
St. George's Hospital
London, , United Kingdom
University College of London
London, , United Kingdom
Central Manchester University Hospitals NHS Foundation Trust
Manchester, , United Kingdom
Northumberland, Tyne & Wear NHS Foundation Trust of St. Nicholas Hospital
Newcastle upon Tyne, , United Kingdom
St. Andrews Healthcare
Northampton, , United Kingdom
Oxford Radcliffe Hospitals
Oxford, , United Kingdom
Plymouth Hospitals NHS Trust
Plymouth, , United Kingdom
Poole Hospital
Poole, , United Kingdom
Royal Berkshire NHS Foundation Trust
Reading, , United Kingdom
Sheffield Children's NHS Foundation Trust
Sheffield, , United Kingdom
University Hospital Southampton
Southampton, , United Kingdom
North Staffordshire Combined Healthcare NHS Trust
Stoke-on-Trent, , United Kingdom
Avon and Wiltshire Mental Health Partnership
Swindon, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
L
Role: backup
Cristina Januário
Role: primary
Ana Oliveira
Role: primary
Leonor C Guedes
Role: backup
Serge Jaumà Classen
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Gray SM, Dai J, Smith AC, Beckley JT, Rahmati N, Lewis MC, Quirk MC. Changes in 24(S)-Hydroxycholesterol Are Associated with Cognitive Performance in Early Huntington's Disease: Data from the TRACK and ENROLL HD Cohorts. J Huntingtons Dis. 2024 Nov;13(4):449-465. doi: 10.3233/JHD-240030.
Langbehn DR, Sathe SS, Loy C, Sampaio C, Mccusker EA. A Phenotypic Atlas for Huntington Disease Based on Data From the Enroll-HD Cohort Study. Neurol Genet. 2023 Nov 28;9(6):e200111. doi: 10.1212/NXG.0000000000200111. eCollection 2023 Dec.
Landwehrmeyer GB, Fitzer-Attas CJ, Giuliano JD, Goncalves N, Anderson KE, Cardoso F, Ferreira JJ, Mestre TA, Stout JC, Sampaio C. Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease. Mov Disord Clin Pract. 2016 Jun 22;4(2):212-224. doi: 10.1002/mdc3.12388. eCollection 2017 Mar-Apr.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Enroll -HD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.